NEMIS Technologies AG
- Industry
- Biotechnology
- Founded Year
- 2018
- Headquarters
- Riedhofstrasse 11, 8804 Zurich, Switzerland
- Employee Count
- 17
Key People
- Arnaud Muller - Co-Founder & Chief Executive Officer
- Mario Hupfeld - Co-Founder & Chief Technology Officer
- Urs Breitenstein - Co-Founder & Chief Financial Officer
- Roger Meier - Co-Founder & Chairman of the Board
- Urs Spitz Ph.D - Co-Founder & Board Member
Assessment
- Team
-
Aspect: Multiple successful MedTech entrepreneurs
Summary: The founding team comprises experienced entrepreneurs and scientists with a strong background in biotechnology and diagnostics.
The leadership team includes individuals with significant experience in biotechnology and diagnostics, enhancing the company's potential for success.
- Clinical Need
-
Aspect: Very Strong
Summary: Rapid and accurate pathogen detection is crucial for food safety and public health.
The increasing incidence of foodborne illnesses underscores the necessity for effective pathogen detection solutions.
- Competition
-
Aspect: Somewhat crowded
Summary: The market has several players offering pathogen detection solutions.
While the market is competitive, NEMIS's unique technology may provide a competitive edge.
- Technical Challenge
-
Aspect: Predictable
Summary: The technology is based on established principles with manageable development risks.
The company's technology leverages known scientific principles, reducing development uncertainties.
- Patent
-
Aspect: Strong
Summary: The company holds multiple patents related to its detection technology.
Patents covering key aspects of the technology provide a barrier to entry for competitors.
- Financing
-
Aspect: Well-funded
Summary: The company has secured significant funding through multiple investment rounds.
The Series A funding round of CHF 7.75 million enables scaling of production and international expansion.
- Regulatory
-
Aspect: 510k/PMA
Summary: The company's products are subject to regulatory approvals for market entry.
Compliance with regulatory standards is critical for product approval and market access.
Opportunity Rollup
- Odds of Success
- 3.7
- Peak Market Share
- 4.7
- Segment CAGR
- 1.9%
- Market Segment
- In Vitro Diagnostics
- Market Sub Segment
- Food Safety Testing
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.24 |
| 2 | 0.70 |
| 3 | 1.64 |
| 4 | 3.29 |
| 5 | 4.70 |
Key Takeaway
NEMIS Technologies AG is well-positioned to address critical needs in food safety with its innovative pathogen detection solutions, supported by a strong team and substantial funding.